Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-03-30
1998-01-27
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 540555, 540560, A61K 3155, C07D24306
Patent
active
057122741
ABSTRACT:
Thienotriazolodiazepine compounds of the formula (1) ##STR1## wherein each symbol is as defined in the specification, pharmaceutically acceptable salts thereof, and pharmaceutical use thereof. The compounds of the present invention are useful as preventive and therapeutic drugs for inflammatory diseases and allergic diseases, in which cell adhesion is involved.
REFERENCES:
patent: 4017620 (1977-04-01), Kuwada et al.
patent: 4992437 (1991-02-01), Naka et al.
Tahara et al, Chemical Abstract 120:270466 (1993) with STN Printout.
Weber et al, Chem. Abstract 113:191406 (1990) with STN Printout.
Derwent Abstract of JP-A-3-223290 (1990).
Derwent Abstract of JP-A-005756 corresponding to JP-B-57-45755 (1974).
Derwent Abstract of DE-3936828 corresponding to JP-A-243691 (1989).
Derwent Abstract of DE-4006471 corresponding to JP-A-2-275883 (1990).
Derwent Abstract of EP-320,992 corresponding to JP-A-1-197484 (1989).
Derwent Abstrct of JP-A-297479 (1993).
Derwent Abstract of WO89/05812 (1989).
Derwent Abstract of WO93/12117 (1993).
Derwent Abstract of WO94/22872 (1994).
Derwent Abstract of WO93/07129 (1993).
Arichi Takeshi
Ehara Shuji
Kobayashi Haruhito
Komatsu Hirotsugu
Sueoka Hiroyuki
Coleman Brenda
Ford John M.
Yoshitomi Pharmaceutical Industries Ltd.
LandOfFree
Thienotriazolodiazepine compounds and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thienotriazolodiazepine compounds and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thienotriazolodiazepine compounds and their pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342555